Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • UK
  • Clinic Portal Login
  • +44 (0)20 8068 8176
  • Request Information
  • +44 (0)20 8068 8176
United KingdomUnited Kingdom
  • Part of brands: |
  • Reproductive Health
    • Specialists
      • EndomeTRIO
      • ERA
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • PGT-A with ploidy
      • EMBRACE
      • PGT-SR
      • PGT-M
      • Infertility Panels
      • POC PORTFOLIO
      • NACE (NIPT)
      • SAT
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
  • User Manual
  • Send a Sample
  • Academy
Genomics Precision Diagnostic > Gastroenterology > Gastroenterology Alagille Syndrome Panel

Alagille Syndrome Panel

The Igenomix Alagille Syndrome Panel can be used to make a directed and accurate differential diagnosis of jaundice in the newborn, for an early initiation of treatment leading to a better prognosis of the disease. 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • The Igenomix Alagille Syndrome Panel can be used to make a directed and accurate differential diagnosis of jaundice in the newborn, for an early initiation of treatment leading to a better prognosis of the disease.  
  • Alagille syndrome is a disorder that is associated with problems in several different body organs including – liver disease, congenital heart conditions, abnormalities in the eye and characteristic facial features.
  • Alagille syndrome can present differently, and the clinical symptoms of affected individuals can be very variable. It is characterized by an obstruction of the biliary tree and decreased excretion of bilirubin causing hyperbilirubinemia and jaundice.
  •  The different manifestations of Alagille syndrome can be deadly if treatment and management is not administered appropriately. This condition is inherited in an autosomal dominant manner and most cases occur due to a de novo variant. Additionally, Alagille syndrome is associated with variable expression and so the clinical features cannot be predicted with molecular testing.  

Indication

The Igenomix Alagille Syndrome Panel is indicated for those patients with a clinical suspicion  or diagnosis of the disease, presenting with the following symptoms: 

  • Hepatic anomalies  
  • Renal anomalies  
  • Cardiac anomalies  
  • Characteristic facial features  
  • Eye problems  
  • Bile duct paucity  
  • Abnormality in the vertebrae  

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular diagnosis for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team. 
  • Risk assessment of asymptomatic family members according to the mode of inheritance. 

Genes & Diseases

Methodology

References

See scientific referrals

Mitchell, E., Gilbert, M., & Loomes, K. M. (2018). Alagille Syndrome. Clinics in liver disease, 22(4), 625–641. https://doi.org/10.1016/j.cld.2018.06.001 

Turnpenny, P. D., & Ellard, S. (2012). Alagille syndrome: pathogenesis, diagnosis and management. European journal of human genetics: EJHG, 20(3), 251–257. https://doi.org/10.1038/ejhg.2011.181 

Ayoub, M. D., & Kamath, B. M. (2020). Alagille Syndrome: Diagnostic Challenges and Advances in Management. Diagnostics (Basel, Switzerland), 10(11), 907. https://doi.org/10.3390/diagnostics10110907 

Ohashi, K., Togawa, T., Sugiura, T., Ito, K., Endo, T., Aoyama, K., Negishi, Y., Kudo, T., Ito, R., & Saitoh, S. (2017). Combined genetic analyses can achieve efficient diagnostic yields for subjects with Alagille syndrome and incomplete Alagille syndrome. Acta paediatrica (Oslo, Norway : 1992), 106(11), 1817–1824. https://doi.org/10.1111/apa.13981 

descargar

Detail description

Download

Request Information


WE GUIDE YOU Fertility Inherited diseases prevention Healthy pregnancy
Click to view our ISO: 15189 accreditation
OUR SERVICES Genetic solutions For patients Sending samples and documentation
ABOUT US About Igenomix Contact User manual Work with us
FOLLOW IGENOMIX
  020 8068 8176 Email us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country
[2024] © Igenomix Privacy policy Quality policy Legal note Cookies policy       Complaints form

Request Information

Copyright 2025 © UX Themes
  • Reproductive Health
    • Specialists
      • EndomeTRIO
      • ERA
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • PGT-A with ploidy
      • EMBRACE
      • PGT-SR
      • PGT-M
      • Infertility Panels
      • POC PORTFOLIO
      • NACE (NIPT)
      • SAT
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
  • User Manual
  • Send a Sample
  • Academy
  • WooCommerce not Found
  • Newsletter
  • UK
  • Clinic Portal Login

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

United Kingdom
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.